Delivery Order SPE2DB20D1100-SPE2DB25FE1P3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $96,898.94 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) with a ceiling value of $3,276.40. This competitively awarded, non-set-aside delivery order operates under a firm fixed-price structure with an ultimate completion date of August 5, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $25,102.49. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a pediatric delivery against AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,023.83 on July 28, 2025, for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 29, 2025, and fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Abiroterone Acetate is a hormone therapy medication commonly used in cancer treatment, reflecting the Defense...
- This is a $9,372.25 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency for the supply of Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, providing a comprehensive global...
- This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of 4,568,117,504 units of Abiraterone Acetate 500 mg tablets. The firm-fixed-price delivery order, valued at $9,966.38, has a period of performance through May 5, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $18,378.63 to Amerisourcebergen Drug Corporation for the supply of 60 units of 500 mg Abiraterone Acetate tablets. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. Performance is scheduled to be completed by July 26, 2023 under a firm fixed price contract type. No set aside designation or...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1P3Delivery Order
The Defense Logistics Agency awarded a $46,593.78 delivery order to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed price contract has no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. This delivery order is representative of the company's extensive federal portfolio, which encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The underlying SPE2DX contract functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.6k | 8/19/25 |